Sharon Bio-medicine Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Sharon Bio-medicine Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $2.1M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Sharon Bio-medicine Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $2.1M Trade | TransData Nexus

Sharon Bio-medicine Limited

Indian Pharmaceutical Exporter · Gastrointestinal Specialist · $2.1M Total Trade · DGFT Verified

Sharon Bio-medicine Limited is an Indian pharmaceutical exporter with a total trade value of $2.1M across 2 products in 2 therapeutic categories. Based on 130 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Loperamide ($2.0M), Pravastatin ($168.3K), .

Sharon Bio-medicine Limited — Export Portfolio & Destination Treemap

Sharon Bio-medicine Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Sharon Bio-medicine Limited? — Company Overview & Market Position

Sharon Bio-Medicine Limited, established on June 19, 1989, in Panvel, Maharashtra, India, has evolved from a manufacturer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) to a comprehensive provider of pharmaceutical products and services. The company is listed on the Bombay Stock Exchange under the ticker symbol 532908. Its Corporate Identification Number (CIN) is U24110MH1989PLC052251. The registered office is located at Plot No. L6, Taloja M.I.D.C, Dist Raigad, Navi Mumbai, Maharashtra 410208, India. As of the latest available data, Sharon Bio-Medicine Limited employs approximately 258 professionals. The company's website is www.sharonbio.com.

What Does Sharon Bio-medicine Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Loperamide$2.0M 2Pravastatin$168.3K

Sharon Bio-medicine Limited Therapeutic Categories — 2 Specializations

Product Portfolio — Top 2 by Export Value

Sharon Bio-medicine Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Loperamide	Gastrointestinal	$2.0M	109	1.7%	8
2	Pravastatin	Cardiovascular	$168.3K	21	0.5%	10

Sharon Bio-medicine Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $2.1M. The top category is Gastrointestinal (92.1% of portfolio), followed by Cardiovascular (7.9%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Sharon Bio-medicine Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Sharon Bio-Medicine Limited operates two primary manufacturing facilities:

1. API Manufacturing Facility: Located at Plot No. L-6, M.I.D.C. Taloja, Navi Mumbai, Maharashtra, this facility specializes in the production of pharmaceutical intermediates and APIs. It is cGMP compliant, adhering to national and international standards, and has received approvals from the US FDA, EU GMP, and WHO GMP.

2. Oral Solid Dosage Manufacturing Facility: Situated in Dehradun, India, this facility focuses on the production of oral solid dosage forms, including tablets and capsules. It is approved by the UK MHRA, Health Canada, Invima (Colombia), and has received desktop TGA approval from its customers.

3Key Leadership

As of June 17, 2025, the key executives at Sharon Bio-Medicine Limited are:

Purushottam Sharma: Director

Mukeshkumar Siyaram Singh: Whole-Time Director

Mahendar Korthiwada: Director

The company's leadership is committed to steering Sharon Bio-Medicine Limited towards its strategic objectives in the pharmaceutical industry.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Sharon Bio-medicine Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Sharon Bio-Medicine Limited has established a presence in several regulated markets:

United States: The company's API manufacturing facility is approved by the US FDA, ensuring compliance with stringent regulatory standards.

European Union: The same facility holds EU GMP certification, facilitating access to European markets.

United Kingdom: The oral solid dosage manufacturing facility in Dehradun is approved by the UK MHRA, indicating adherence to UK regulatory requirements.

Canada: The Dehradun facility also holds approval from Health Canada, expanding its reach in North America.

Australia: While the Dehradun facility has received desktop TGA approval from its customers, specific TGA certification details are not publicly disclosed.

Emerging Markets

Sharon Bio-medicine Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Sharon Bio-Medicine Limited's FDA-related activities include:

Facility Registration: The API manufacturing facility in Taloja is registered with the US FDA, ensuring compliance with FDA regulations.

Approved ANDAs: Specific details regarding approved Abbreviated New Drug Applications (ANDAs) are not publicly disclosed.

DMF Filings: The company has filed Drug Master Files (DMFs) with the FDA, facilitating the approval process for its products.

Inspection History: There are no publicly available records of FDA inspections or observations for Sharon Bio-Medicine Limited.

2WHO & EU GMP

Sharon Bio-medicine Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Sharon Bio-Medicine Limited operates in a competitive pharmaceutical industry, facing competition from both domestic and international companies. Its focus on high-quality manufacturing and regulatory compliance positions it favorably in the market. However, specific market share comparisons and head-to-head analyses are not publicly available.

2Key Differentiators

Sharon Bio-Medicine Limited's key differentiators include:

Integrated Services: The company offers a comprehensive range of services, from preclinical toxicology to commercial manufacturing, providing end-to-end solutions for its clients.

Regulatory Approvals: With certifications from regulatory bodies such as the US FDA, EU GMP, and WHO GMP, Sharon Bio-Medicine Limited demonstrates its commitment to quality and compliance.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Sharon Bio-medicine Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Sharon Bio-Medicine Limited's track record includes:

Export Volume and Consistency: The company has a total export value of $2.1 million USD across 130 shipments, indicating a consistent export performance.

Reliability Indicators: The company's adherence to international quality standards and regulatory approvals reflects its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications when considering Sharon Bio-Medicine Limited as a supplier:

FDA: Verify through the FDA's official website or contact the company directly.

WHO-GMP: Confirm via the World Health Organization's official website or the company's certifications.

Frequently Asked Questions — Sharon Bio-medicine Limited

How many pharmaceutical products does Sharon Bio-medicine Limited export from India?

Sharon Bio-medicine Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Loperamide ($2.0M), Pravastatin ($168.3K). Total export value is $2.1M.

What is Sharon Bio-medicine Limited's total pharmaceutical export value?

Sharon Bio-medicine Limited's total pharmaceutical export value is $2.1M, based on 130 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Sharon Bio-medicine Limited cover?

Sharon Bio-medicine Limited exports across 2 therapeutic categories. The largest are Gastrointestinal (92.1%, 1 products), Cardiovascular (7.9%, 1 products).

Get Full Sharon Bio-medicine Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.